To study the medical characteristics and genetic foundation of complete androgen insensitivity syndrome (CAIS) in sufferers from the People’s Republic of China. CAIS sufferers with 46 XY karyotype produce male ranges of androgens however current with feminine exterior genitalia and secondary intercourse characteristics. The majority of affected people have androgen receptor (AR) gene mutations. This case series explored medical and molecular characteristics of CAIS sufferers from the People’s Republic of China. Genomic DNA from peripheral blood of clinically recognized CAIS sufferers was sequenced for mutation within the androgen receptor (AR) gene and steroid 5α-reductase sort 2 gene (SRD5A2).
A Qualtrics survey was despatched to doctor trainees who rotated in genetics earlier than or midpandemic. Questions assessed affected person care, didactic schooling, and competency in a number of domains. Number of clinic visits accomplished by trainees had been collated by way of overview of documentation. Twenty-three rotating residents accomplished the surveys. Five of the pediatric residents accomplished the elective through the pandemic. All residents participated in digital care through the pandemic, and rotating residents reported an enchancment in self-assessed competency in a number of domains. Potential weak areas of schooling midpandemic included dysmorphology and genetic counseling.
Participants had been recruited from Peking Union Medical College Hospital once they got here in for session. Thirty sufferers from unrelated households had been recruited. Data from medical paperwork recording analysis and therapy of these sufferers had been retrospectively collected. Patient genotypes had been decided by sequencing the AR and SRD5A2 genes. Their medical characteristics had been summarized based mostly on Twenty-one sufferers recognized with CAIS had mutations in AR exons. Analysis of AR exons revealed the presence of seven novel mutations; of these mutations, 47.6% (10/21) had been situated within the ligand-binding area. Gonadal insufficiency was present in one case of CAIS. Among the remaining 9 sufferers, three had SRD5A2 mutations and due to this fact a steroid 5α-reductase deficiency. No AR or SRD5A2 mutations had been detected within the different six sufferers.
20-year expertise on prenatal analysis in a reference college medical genetics center in Turkey
Although leading edge procedures similar to cell-free fetal DNA isolation from maternal blood are actually accessible, invasive prenatal assessments are nonetheless getting used extensively for prenatal analysis. The purpose of this study is to judge the demographic knowledge, indications and cytogenetic outcomes of 9297 outcomes of sufferers who underwent prenatal invasive testing for genetic evaluation that had been referred for the final 20 years in a University Medical Genetics Center. The data of 8363 amniocentesis, 626 chorionic villus and 308 cordocentesis samples had been retrospectively evaluated and analyzed in regard to referral causes, indications and their cytogenetic outcomes. The whole numbers and the chances of every group had been recorded; Chi-square and logistic regression evaluation had been carried out as a way to give the statistical chance of completely different occasions.
The quantity of referrals decreased considerably after 2009. Risk of having trisomy 21 in addition to trisomy 13 and 18 considerably elevated in parallel with superior maternal age. When the 21-25 age group was in comparison with the older age teams in phrases of having a trisomy 21 being pregnant, the danger doubled within the 36-40, 5 occasions increased in 41-45 and 10-fold in 46-50 age teams. No important linear correlation between maternal serum screening take a look at outcomes and trisomy 21 was discovered, nevertheless the distinction between the pregnancies whom cut-off worth above and beneath 1/250 in maternal serum screening take a look at had been important.
These knowledge have offered helpful data on the frequency of referrals to the reference genetics division, and the feasibility of genetic companies. By reviewing the indications and their corresponding outcomes, we will supply invaluable insights that shall be helpful in genetic counseling and additionally within the improvement of more practical genetic methods.

Barriers and methods to combine medical genetics and main care in underserved populations: a scoping overview
Despite medical and technological advances, critical gaps stay in delivering genetic companies on account of disparities in workforce distribution and lack of protection for genetic testing and counseling. Genetic companies supply, notably in medically underserved populations, might rely closely on main care suppliers (PCPs). This study goals to establish boundaries to integrating genetic companies and main care, and methods to assist integration, by conducting a scoping overview.
Literature synthesis discovered boundaries most regularly cited by PCPs together with inadequate information about genetics and danger evaluation, lack of entry to geneticists, and inadequate time to deal with these challenges. Telegenetics, patient-centered care, and studying communities are methods to beat these boundaries. Telegenetics dietary supplements face-to-face clinics by offering distant entry to genetic companies. It can also be used for doctor consultations and schooling. Patient-centered care permits suppliers, households, and sufferers to coordinate companies and sources. Access to skilled data gives a important useful resource for PCPs.
Tissue Factor Antibody |
|
49112-50ul |
SAB |
50ul |
EUR 286.8 |
Tissue Factor antibody |
|
MBS832241-10mg |
MyBiosource |
10mg |
EUR 560 |
Tissue Factor antibody |
|
MBS832241-5x10mg |
MyBiosource |
5x10mg |
EUR 2370 |
Tissue Factor Antibody |
|
MBS9435884-005mL |
MyBiosource |
0.05mL |
EUR 325 |
Tissue Factor Antibody |
|
MBS9435884-01mL |
MyBiosource |
0.1mL |
EUR 435 |
Tissue Factor Antibody |
|
MBS9435884-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1810 |
Tissue Factor (F3) Antibody |
|
20-abx001211 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ul
- 50 ul
- 100 ul
- 200 ul
|
|
|
Tissue Factor (F3) Antibody |
|
abx037991-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
|
Tissue Factor (F3) Antibody |
|
20-abx100873 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tissue Factor (TF) Antibody |
|
abx100874-100l |
Abbexa |
100 µl |
EUR 250 |
Tissue Factor (TF) Antibody |
|
20-abx100874 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody |
|
abx100874-1ml |
Abbexa |
1 ml |
EUR 675 |
Tissue Factor (TF) Antibody |
|
abx100874-200l |
Abbexa |
200 µl |
EUR 312.5 |
Tissue Factor (TF) Antibody |
|
abx100875-100l |
Abbexa |
100 µl |
EUR 262.5 |
Tissue Factor (TF) Antibody |
|
20-abx100875 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody |
|
abx100875-1ml |
Abbexa |
1 ml |
EUR 687.5 |
Tissue Factor (TF) Antibody |
|
abx100875-200l |
Abbexa |
200 µl |
EUR 325 |
Tissue Factor (F3) Antibody |
|
20-abx100876 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody |
|
abx100877-100l |
Abbexa |
100 µl |
EUR 262.5 |
Tissue Factor (TF) Antibody |
|
20-abx100877 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody |
|
abx100877-1ml |
Abbexa |
1 ml |
EUR 725 |
Tissue Factor (TF) Antibody |
|
abx100877-200l |
Abbexa |
200 µl |
EUR 337.5 |
Tissue Factor (TF) Antibody |
|
abx100878-100l |
Abbexa |
100 µl |
EUR 275 |
Tissue Factor (TF) Antibody |
|
20-abx100878 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody |
|
abx100878-1ml |
Abbexa |
1 ml |
EUR 775 |
Tissue Factor (TF) Antibody |
|
abx100878-200l |
Abbexa |
200 µl |
EUR 350 |
Tissue factor (F3) Antibody |
|
20-abx323788 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tissue factor (F3) Antibody |
|
20-abx339467 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tissue Factor (TF) Antibody |
|
abx132340-01mg |
Abbexa |
0.1 mg |
EUR 275 |
Tissue Factor (TF) Antibody |
|
20-abx132340 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue factor (F3) Antibody |
|
abx402379-500g |
Abbexa |
500 µg |
EUR 287.5 |
Tissue factor (F3) Antibody |
|
20-abx210516 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tissue Factor (TF) Antibody |
|
20-abx174801 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody |
|
abx174801-250mg |
Abbexa |
250 mg |
EUR 337.5 |
Tissue Factor (TF) Antibody |
|
abx174801-50mg |
Abbexa |
50 mg |
EUR 262.5 |
Tissue Factor (TF) Antibody |
|
abx174802-100g |
Abbexa |
100 g |
EUR 350 |
Tissue Factor (TF) Antibody |
|
20-abx174802 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody |
|
abx174802-25g |
Abbexa |
25 g |
EUR 275 |
Tissue Factor (TF) Antibody |
|
20-abx174803 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tissue Factor (TF) Antibody |
|
20-abx178602 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tissue Factor (TF) Antibody |
|
abx178602-96tests |
Abbexa |
96 tests |
EUR 262.5 |
Tissue Factor (TF) Antibody |
|
20-abx178604 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tissue Factor (F3) Antibody |
|
abx117088-100ug |
Abbexa |
100 ug |
EUR 560.4 |
|
|
Tissue Factor (TF) Antibody |
|
20-abx270078 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody |
|
abx270078-1ml |
Abbexa |
1 ml |
EUR 387.5 |
Tissue Factor (TF) Antibody |
|
abx270078-200l |
Abbexa |
200 µl |
EUR 275 |
Tissue Factor (TF) Antibody |
|
20-abx270129 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody |
|
abx270129-1ml |
Abbexa |
1 ml |
EUR 425 |
Tissue Factor (TF) Antibody |
|
abx270129-200l |
Abbexa |
200 µl |
EUR 300 |
Tissue Factor (TF) Antibody |
|
20-abx270230 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (F3) Antibody |
|
20-abx303791 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody |
|
abx104870-100g |
Abbexa |
100 µg |
EUR 812.5 |
Tissue Factor (TF) Antibody |
|
20-abx104870 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody |
|
abx104870-20g |
Abbexa |
20 µg |
EUR 287.5 |
Tissue Factor (TF) Antibody |
|
abx104870-50g |
Abbexa |
50 µg |
EUR 362.5 |
Tissue factor (F3) Antibody |
|
20-abx325045 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tissue Factor antibody (HRP) |
|
MBS833149-02mg |
MyBiosource |
0.2mg |
EUR 660 |
Tissue Factor antibody (HRP) |
|
MBS833149-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2820 |
Tissue factor Antibody (FITC) |
|
GWB-497E4F |
GenWay Biotech |
0.025 mg |
Ask for price |
|
|
Tissue Factor (TF) Antibody (PE) |
|
20-abx270840 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody (PE) |
|
abx270840-1ml |
Abbexa |
1 ml |
EUR 1125 |
Tissue Factor (TF) Antibody (PE) |
|
abx270840-200l |
Abbexa |
200 µl |
EUR 687.5 |
Tissue Factor (TF) Antibody (PE) |
|
20-abx270891 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody (PE) |
|
abx270891-1ml |
Abbexa |
1 ml |
EUR 1125 |
Tissue Factor (TF) Antibody (PE) |
|
abx270891-200l |
Abbexa |
200 µl |
EUR 687.5 |
Tissue Factor (TF) Antibody (PE) |
|
20-abx270992 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (CD142) Antibody |
|
abx140398-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
|
Tissue Factor (CD142) Antibody |
|
20-abx141195 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Tissue Factor (CD142) Antibody |
|
abx411647-01mg |
Abbexa |
0.1 mg |
EUR 526.8 |
|
|
Tissue Factor (CD142) Antibody |
|
abx414339-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
|
Tissue Factor (TF) Antibody (APC) |
|
20-abx270760 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody (APC) |
|
20-abx270608 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody (APC) |
|
abx270608-1ml |
Abbexa |
1 ml |
EUR 1312.5 |
Tissue Factor (TF) Antibody (APC) |
|
abx270608-200l |
Abbexa |
200 µl |
EUR 800 |
Tissue Factor (TF) Antibody (APC) |
|
20-abx270659 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody (APC) |
|
abx270659-1ml |
Abbexa |
1 ml |
EUR 1312.5 |
Tissue Factor (TF) Antibody (APC) |
|
abx270659-200l |
Abbexa |
200 µl |
EUR 800 |
Tissue Factor (TF) Antibody (APC) |
|
20-abx178603 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tissue Factor (F3) Antibody (HRP) |
|
20-abx303792 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody (FITC) |
|
abx274001-100mg |
Abbexa |
100 mg |
EUR 975 |
Tissue Factor (TF) Antibody (FITC) |
|
20-abx274001 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody (FITC) |
|
abx274001-20mg |
Abbexa |
20 mg |
EUR 412.5 |
Tissue Factor (TF) Antibody (FITC) |
|
abx274137-05ml |
Abbexa |
0.5 ml |
EUR 425 |
Tissue Factor (TF) Antibody (FITC) |
|
20-abx274137 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody (FITC) |
|
20-abx270427 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody (FITC) |
|
abx270427-1ml |
Abbexa |
1 ml |
EUR 912.5 |
Tissue Factor (TF) Antibody (FITC) |
|
abx270427-200l |
Abbexa |
200 µl |
EUR 575 |
Tissue Factor (TF) Antibody (FITC) |
|
20-abx270528 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody Pair |
|
abx370347-100g |
Abbexa |
100 µg |
EUR 1312.5 |
Tissue Factor (TF) Antibody Pair |
|
20-abx370347 |
Abbexa |
-
Ask for price
-
Ask for price
|
- 5 × 96 tests
- 10 × 96 tests
|
|
|
Tissue Factor (TF) Antibody (FITC) |
|
20-abx270376 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
Tissue Factor (TF) Antibody (FITC) |
|
abx270376-1ml |
Abbexa |
1 ml |
EUR 912.5 |
Tissue Factor (TF) Antibody (FITC) |
|
abx270376-200l |
Abbexa |
200 µl |
EUR 575 |
Tissue Factor (F3) Antibody (FITC) |
|
20-abx303793 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody (FITC) |
|
20-abx273794 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody (FITC) |
|
abx273794-25mg |
Abbexa |
25 mg |
EUR 950 |
Tissue Factor (TF) Antibody (FITC) |
|
abx273794-5mg |
Abbexa |
5 mg |
EUR 400 |
Mouse Tissue Factor (TF) Antibody |
|
32800-05111 |
AssayPro |
150 ug |
EUR 215 |
Human Tissue Factor (TF) Antibody |
|
11611-05011 |
AssayPro |
150 ug |
EUR 175 |
Tissue Factor (TF) Antibody (Biotin) |
|
20-abx271994 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody (Biotin) |
|
abx271994-1ml |
Abbexa |
1 ml |
EUR 737.5 |
Tissue Factor (TF) Antibody (Biotin) |
|
abx271994-200l |
Abbexa |
200 µl |
EUR 337.5 |
Tissue Factor (TF) Antibody (Biotin) |
|
20-abx272699 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody (Biotin) |
|
abx272699-1ml |
Abbexa |
1 ml |
EUR 762.5 |
Tissue Factor (TF) Antibody (Biotin) |
|
abx272699-200l |
Abbexa |
200 µl |
EUR 337.5 |
Tissue Factor (TF) Antibody (Biotin) |
|
20-abx273044 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody (Biotin) |
|
abx273044-10mg |
Abbexa |
10 mg |
EUR 362.5 |
Tissue Factor (TF) Antibody (Biotin) |
|
abx273044-50mg |
Abbexa |
50 mg |
EUR 800 |
Tissue Factor (TF) Antibody (Biotin) |
|
abx273176-100mg |
Abbexa |
100 mg |
EUR 800 |
Tissue Factor (TF) Antibody (Biotin) |
|
20-abx273176 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Tissue Factor (TF) Antibody (Biotin) |
|
abx273176-20mg |
Abbexa |
20 mg |
EUR 362.5 |
Tissue Factor (F3) Antibody (Biotin) |
|
20-abx303794 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Sheep anti-Human Tissue Factor polyclonal antibody |
|
CABT-L422 |
Creative Diagnostics |
10 mg |
EUR 579.6 |
|
Description: Sheep |
Sheep anti-Human Tissue Factor polyclonal antibody |
|
CABT-L423 |
Creative Diagnostics |
200ug |
EUR 579.6 |
|
Description: Sheep |
Mouse anti-Human Tissue Factor monoclonal antibody |
|
CABT-L424 |
Creative Diagnostics |
100ug |
EUR 579.6 |
|
Description: Mouse |
Mouse anti-Human Tissue Factor monoclonal antibody |
|
CABT-L425 |
Creative Diagnostics |
100ug |
EUR 579.6 |
|
Description: Mouse |
Tissue Factor polyclonal antibody |
|
BS91349 |
Bioworld Biotech |
50ul |
EUR 398 |
|
|
|
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
Tissue Factor Conjugated Antibody |
|
C49112 |
SAB |
100ul |
EUR 476.4 |
Tissue Factor monoclonal antibody |
|
MB11807 |
Bioworld Biotech |
50ul |
EUR 398 |
|
|
|
Description: 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA |
Tissue Factor monoclonal antibody |
|
MB12278 |
Bioworld Biotech |
50ul |
EUR 398 |
|
|
|
Description: 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA |
Tissue Factor monoclonal antibody |
|
MB12279 |
Bioworld Biotech |
50ul |
EUR 398 |
|
|
|
Description: 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA |
Tissue Factor Conjugated Antibody |
|
MBS9456807-01mLAF350 |
MyBiosource |
0.1mL(AF350) |
EUR 480 |
Tissue Factor Conjugated Antibody |
|
MBS9456807-01mLAF405 |
MyBiosource |
0.1mL(AF405) |
EUR 480 |
Tissue Factor Conjugated Antibody |
|
MBS9456807-01mLAF488 |
MyBiosource |
0.1mL(AF488) |
EUR 480 |
Tissue Factor Conjugated Antibody |
|
MBS9456807-01mLAF555 |
MyBiosource |
0.1mL(AF555) |
EUR 480 |
Tissue Factor Conjugated Antibody |
|
MBS9456807-01mLBiotin |
MyBiosource |
0.1mL(Biotin) |
EUR 480 |
Mouse Anti-Rat Tissue Factor (TF) Monoclonal Antibody |
|
VD2N232 |
BioVenic |
1 Each |
Ask for price |
Tissue Factor (CD142) Antibody (FITC) |
|
abx414337-01mg |
Abbexa |
0.1 mg |
EUR 610.8 |
|
|
Tissue Factor (CD142) Antibody (FITC) |
|
abx414338-25ug |
Abbexa |
25 ug |
EUR 326.4 |
|
|
Goat anti-Connective Tissue Growth Factor Antibody |
|
MBS423707-01mg |
MyBiosource |
0.1mg |
EUR 400 |
Goat anti-Connective Tissue Growth Factor Antibody |
|
MBS423707-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1660 |
Rat Tissue Factor Antibody Pair Set |
|
ABPR-ZB302 |
Creative Diagnostics |
5 plates, 15 plates |
Ask for price |
|
Description: Quantitative determination of Rat Tissue Factor |
Rabbit Anti-Rat Tissue Factor (TF) Polyclonal Antibody |
|
VD1N484 |
BioVenic |
1 Each |
Ask for price |
Mouse Anti-Mouse Tissue Factor (TF) Monoclonal Antibody |
|
VD4N239 |
BioVenic |
1 Each |
Ask for price |
Rabbit anti-human Tissue factor polyclonal Antibody(F3) |
|
MBS7005426-005mg |
MyBiosource |
0.05mg |
EUR 190 |
Rabbit anti-human Tissue factor polyclonal Antibody(F3) |
|
MBS7005426-01mg |
MyBiosource |
0.1mg |
EUR 270 |
Rabbit anti-human Tissue factor polyclonal Antibody(F3) |
|
MBS7005426-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
Rabbit Anti-Mouse Tissue Factor (TF) Polyclonal Antibody |
|
VD3N723 |
BioVenic |
1 Each |
Ask for price |
Mouse Anti-Rabbit Tissue Factor (TF) Monoclonal Antibody |
|
VD4N197 |
BioVenic |
1 Each |
Ask for price |
Anti-Human Tissue Factor FITC-Conjugated IgG Antibody |
|
MBS4157086-01mL |
MyBiosource |
0.1mL |
EUR 790 |
Anti-Human Tissue Factor FITC-Conjugated IgG Antibody |
|
MBS4157086-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3300 |
Anti-F3 / Factor III / Tissue Factor / CD142 Reference Antibody (tisotumab vedotin) |
|
E24CHB257 |
EnoGene |
100ug |
EUR 275 |
Learning communities might symbolize a mechanism that facilitates data alternate and information sharing amongst completely different suppliers. As PCPs usually play a essential position caring for sufferers with genetic issues in underserved areas, boundaries to main care-medical genetics integration should be addressed to enhance entry. Strategies, similar to telegenetics, promotion of evidence-based tips, point-of-care danger evaluation instruments, tailor-made schooling in genetics-related subjects, and different system-level methods, will facilitate higher genetics and main care integration, which in flip, might enhance genetic service supply to sufferers residing in underserved communities.